乳酸受体GPR81对乳腺癌免疫微环境的增强作用
Shenchao Guo1,2, Jianliang Zhou1, Pengrong Lou1
1Department of Radiotherapy and Chemotherapy, The First Affiliated Hospital of Ningbo University, Ningbo, People's Republic of China.
Molecular carcinogenesis
|May 30, 2023
概括
G蛋白结合受体 (GPR81) 可能有助于三阴性乳腺癌 (TNBC) 逃避免疫检测. 激活GPR81降低PD-L1,可能在某些乳腺癌中增强抗瘤免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- G蛋白结合受体 (GPR81) 作为乳酸受体,在免疫调节中出现.
- 它在瘤免疫逃避中的确切作用,特别是在乳腺癌中,仍然不完全理解.
研究的目的:
- 研究GPR81激活对三阴性乳腺癌 (TNBC) 细胞和巨细胞的影响.
- 使用TCGA数据分析GPR81表达模式及其与乳腺癌免疫透的相关性.
主要方法:
- 对GPR81表达和免疫透相关性的TCGA数据库分析.
- 流细胞计和ELISA用于评估免疫检查点和细胞因子水平.
- 在体外实验中,涉及GPR81激动剂治疗和siRNA在TNBC和巨细胞系中的淘汰.
主要成果:
- 与正常乳腺组织相比,GPR81表达在乳腺癌 (BRCA) 中显著下降,特别是在基底类型的亚型中.
- 刺激GPR81抑制了特定TNBC细胞系 (BT-549,MDA-MB-231) 中的PD-L1表达,这种效应被GPR81淘汰扭转.
- 激活GPR81对PMA诱导的THP-1细胞中PD-L1表达的影响很小,对细胞因子分泌没有显著影响.
结论:
- 通过降低PD-L1表达的调节,GPR81可能会促进糖性TNBC中的免疫监测.
- 向GPR81为乳腺癌提供了潜在的治疗策略,特别是用于增强抗瘤免疫反应.
相关概念视频
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...


